This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/519285-norway-covid19-astrazeneca-vaccine-suspended/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
Norway delays decision on resuming use of AstraZeneca Covid-19 vaccine, verdict to be reached by April 15 Norway delays decision on resuming use of AstraZeneca Covid-19 vaccine, verdict to be reached by April 15
(2 months later)
The Norwegian government has confirmed media reports that it will continue to suspend the use of the heavily criticized AstraZeneca Covid-19 vaccine, and has promised a decision will be made in three weeks.The Norwegian government has confirmed media reports that it will continue to suspend the use of the heavily criticized AstraZeneca Covid-19 vaccine, and has promised a decision will be made in three weeks.
“We have decided to continue the pause and make a new decision by April 15,” said Camilla Stoltenberg, Director General of the Norwegian Institute of Public Health, on Friday, as she addressed speculation around the AstraZeneca vaccine. “We have decided to continue the pause and make a new decision by April 15,” said Camilla Stoltenberg, Director General of the Norwegian Institute of Public Health, on Friday, as she addressed speculation around the AstraZeneca vaccine. 
“We have started several processes to map out whether there is a causality and to have a better basis to establish the real risk and a cost-benefit analysis for different age groups. To get more knowledge, it is necessary to have more time,” the health service chief told broadcaster NRK.“We have started several processes to map out whether there is a causality and to have a better basis to establish the real risk and a cost-benefit analysis for different age groups. To get more knowledge, it is necessary to have more time,” the health service chief told broadcaster NRK.
The decision comes one day after Denmark’s health authority said the country would extend the temporary suspension of the AstraZeneca Covid vaccine for three more weeks, as it can’t rule out a connection between the jab and blood clots. The decision comes one day after Denmark’s health authority said the country would extend the temporary suspension of the AstraZeneca Covid vaccine for three more weeks, as it can’t rule out a connection between the jab and blood clots. 
Like Denmark, Norway suspended the vaccine on March 11 following reports the jab, in very rare cases, caused potentially fatal thromboembolic events. As many as 18 nations paused the use of the Anglo-Swedish shot before the European Medicines Agency (EMA) declared the vaccine “safe and effective” after a thorough review. Like Denmark, Norway suspended the vaccine on March 11 following reports the jab, in very rare cases, caused potentially fatal thromboembolic events. As many as 18 nations paused the use of the Anglo-Swedish shot before the European Medicines Agency (EMA) declared the vaccine “safe and effective” after a thorough review. 
EMA chief Emer Cooke said last Friday that “this is a safe and effective vaccine, its benefits in protecting people from Covid-19, with the associated risks of death and hospitalization, outweigh the possible risks.” EMA chief Emer Cooke said last Friday that “this is a safe and effective vaccine, its benefits in protecting people from Covid-19, with the associated risks of death and hospitalization, outweigh the possible risks.” 
The jab has been widely used across the globe, including in the UK, where it accounts for approximately half of the 32 million jabs administered.The jab has been widely used across the globe, including in the UK, where it accounts for approximately half of the 32 million jabs administered.
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.